IP Library Granted Patent US 11,142,647
Granted Patent B2
US 11,142,647 · App. 15/543,885 · Granted Oct 12, 2021

Ultra bright dimeric or polymeric dyes

Inventors: Tracy Matray (Snohomish, WA); Sharat Singh (Rancho Santa Fe, CA); Michael VanBrunt (Covington, WA)
Assignee: Sony Group Corporation
C09B69/102C07C215/68C07F9/091C07F9/2408C09B69/103C09B69/109G01N33/582
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,142,647
App. No.
15/543,885
Granted
Oct 12, 2021
Kind
B2
Abstract

Compounds useful as fluorescent or colored dyes are disclosed. The compounds have the following structure (I): or a stereoisomer, tautomer or salt thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , L 1 , L 2 , L 3 , L 4 , M, m and n are as defined herein. Methods associated with preparation and use of such compounds are also provided.

Claims (48)

1. A compound having the following structure (I):

or a stereoisomer, salt or tautomer thereof, wherein:

M is, at each occurrence, independently a moiety comprising two or more carbon-carbon double bonds and at least one degree of conjugation, and at least one occurrence of M is a moiety comprising three or more rings selected from aryl and heteroaryl rings;

L 1 is, at each occurrence, independently a linker comprising an alkene, ester, amide, thioester, disulfide, carbocyclic, heterocyclic or heteroaryl group;

L 2 and L 3 are, at each occurrence, independently an optional alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene, heteroalkynylene or heteroatomic linker;

L 4 is, at each occurrence, independently an alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene or heteroalkynylene linker;

R 1 is, at each occurrence, independently H, alkyl or alkoxy;

one of R 2 and R 3 is OH or —OP(═R a )(R b )R c , and the other one of R 2 and R 3 is Q, a linker comprising a covalent bond to Q, a linker comprising a covalent bond to an analyte molecule or a linker comprising a covalent bond to a solid support, wherein: R a is O or S; R b is OH, SH, O − , S − , OR d or SR d ; R c is OH, SH, O − , S − , OR d , SR d , alkyl, alkoxy, alkylether, alkoxyalkylether, phosphate, thiophosphate, phosphoalkyl, thiophosphoalkyl, phosphoalkylether or thiophosphoalkylether; and R d is a counter ion;

R 4 is, at each occurrence, independently OH, SH, O − , S − , OR d or SR d ;

R 5 is, at each occurrence, independently oxo, thioxo or absent;

Q is, at each occurrence, independently a moiety comprising a sulfhydryl, disulfide, activated ester, isothiocyanate azide, alkyne, alkene, diene, dienophile, acid halide, sulfonyl halide, phosphine, α-haloamide, biotin, amino or maleimide functional group;

m is, at each occurrence, independently an integer of zero or greater, wherein at least one occurrence of m is an integer of two or greater; and

n is an integer of one or greater.

2. The compound of claim 1 , wherein for at least one occurrence of L 1 , the functional group can be formed by reaction of an alkyne and azide.

3. The compound of claim 1 , wherein the compound has the following structure (IC):

wherein:

x 1 , x 2 , x 3 and x 4 are, at each occurrence, independently an integer from 0 to 6; and

y is, at each occurrence, independently an integer from 1 to 6.

4. The compound of claim 1 , wherein the compound has one of the following structures (ID) or (IE):

5. The compound of claim 1 , wherein one of R 2 or R 3 is OH or —OP(═R a )(R b )R c , and the other of R 2 or R 3 is Q or a linker comprising a covalent bond to Q.

6. The compound of claim 1 , wherein Q has one of the following structures:

wherein

X is halo; and

EWG is an electron withdrawing group.

7. The compound of claim 1 , wherein one of R 2 and R 3 is OH or —OP(═R a )(R b )R c , and the other of R 2 and R 3 is a linker comprising a covalent bond to an analyte molecule or a linker comprising a covalent bond to a solid support.

8. The compound of claim 7 , wherein the analyte molecule is an enzyme, receptor, receptor ligand, antibody, glycoprotein, aptamer or prion.

9. The compound of claim 1 , wherein m is, at each occurrence, independently an integer from 3 to 10.

10. The compound of claim 1 , wherein m is, at each occurrence, independently an integer from 7 to 9.

11. The compound of claim 1 , wherein M is, at each occurrence, independently fluorescent or colored.

12. The compound of claim 1 , wherein M is, at each occurrence, independently a dimethylaminostilbene, quinacridone, fluorophenyl-dimethyl-BODIPY, his-fluorophenyl-BODIPY, acridine, terrylene, sexiphenyl, porphyrin, benzopyrene, (fluorophenyl-dimethyl-difluorobora-diaza-indacene)phenyl, (bis-fluorophenyl-difluorobora-diaza-indacene)phenyl, quaterphenyl, bi-benzothiazole, ter-benzothiazole, bi-naphthyl, bi-anthracyl, squaraine, squarylium, 9, 10-ethynylanthracene, ter-naphthyl, p-terphenyl, perylene, azobenzene, phenazine, phenanthroline, thioxanthrene, chrysene, rubrene, coronene, cyanine, perylene imide, perylene amide, coumarin dye, resorufin dye, dipyrrometheneboron difluoride dye, ruthenium bipyridyl dye, energy transfer dye, thiazole orange dye, polymethine or N-aryl-1,8-naphthalimide dye moiety.

13. The compound of claim 1 , wherein M is, at each occurrence, independently pyrene, perylene, perylene monoimide or 6-FAM or derivative thereof.

14. The compound of claim 1 , wherein M, at each occurrence, independently has one of the following structures:

15. The compound of claim 1 , wherein the compound is selected from one of the following compounds:

wherein:

L 1 is, at each occurrence, independently a linker comprising a functional group capable of formation by reaction of two complementary reactive groups;

F has the following structure:

E has the following structure:

Y has the following structure:

16. A method of staining a sample, comprising adding to said sample the compound of claim 1 in an amount sufficient to produce an optical response when said sample is illuminated at an appropriate wavelength.

17. A method for visually detecting an analyte molecule, the method comprising:

(a) providing the compound of claim 1 , wherein R 2 or R 3 is a linker comprising a covalent bond to the analyte molecule; and

(b) detecting the compound by its visible properties.

18. A method for visually detecting an analyte molecule, the method comprising:

(a) admixing the compound of claim 1 , wherein R 2 or R 3 is Q or a linker comprising a covalent bond to Q, with the analyte molecule;

(b) forming a conjugate of the compound and the analyte molecule; and

(c) detecting the conjugate by its visible properties.

19. A composition comprising the compound of claim 1 and one or more analyte molecules.

20. The compound of claim 1 , wherein the analyte molecule is a nucleic acid, a nucleic acid polymer, an amino acid or an amino acid polymer.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2020
From: SONY CORPORATION OF AMERICA
To: SONY CORPORATION
Reel/Frame 054751/0070 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2018
From: MATRAY, TRACY; SINGH, SHARAT; VANBRUNT, MICHAEL
To: SONY CORPORATION OF AMERICA; SONY CORPORATION
Reel/Frame 045209/0268 →
Continuity (2)
Provisional Application 62317192 · Apr 1, 2016
Related Publication 20190016898A1 · Jan 17, 2019
Cited By (15)
US 12,194,104 US 12,270,812 US 12,275,851 US 12,290,571 US 12,319,817 US 12,359,071 US 12,391,833 US 12,461,106 US 12,473,433 US 12,539,334 US 12,560,612 US 12,577,403 US 12,578,342 US 12,606,588 US 12,629,425